Foghorn Therapeutics Inc (FHTX) — Tangible Net Worth Ratio
Foghorn Therapeutics Inc (FHTX) has a Tangible Net Worth Ratio of 100.0% as of December 2022. This metric is calculated by deducting intangible assets ($0.00) from net assets ($112.00K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Foghorn Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Foghorn Therapeutics Inc Tangible Net Worth Ratio (2020–2022)
This chart shows how Foghorn Therapeutics Inc's Tangible Net Worth Ratio has changed across 3 annual periods from 2020 to 2022. As of December 2022, the ratio stands at 100.0%, reflecting net assets of $112.00K with intangible assets of $0.00 USD. For live market cap and overall valuation, see FHTX market cap.
Annual Tangible Net Worth Ratio for Foghorn Therapeutics Inc (2020–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Foghorn Therapeutics Inc from 2020 to 2022, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Foghorn Therapeutics Inc (FHTX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | $112.00K | $0.00 | $404.88 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $96.87 Million | $0.00 | $519.77 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $146.19 Million | $0.00 | $255.59 Million | — |